Phoenix Biotech Acquisiti... (PBAXU)
NASDAQ: PBAXU
· Real-Time Price · USD
10.37
-0.01 (-0.10%)
At close: Feb 07, 2024, 3:37 PM
Phoenix Biotech Acquisition Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
Net Income | -5.11M | -5.04M | -4.1M | -334.03K | -1.44M | -481.71K | -262.68K | 84.5K | -111.57K | -378K | -314.55K | -1K |
Depreciation & Amortization | 269.48K | 1.12M | 832.45K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 304.95K | 96.9K | 78.92K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | n/a | 753.41K | 787.72K | 34.31K | -423.66K | -364.06K | 510.23K | 175.44K | 98.21K | -10.22K | -379.51K | n/a |
Other Non-Cash Items | n/a | 666.08K | 542.87K | -121.52K | -150.5K | -108.56K | -1.56M | -981.65K | -265.01K | -26.78K | -16.48K | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | -1.3M | -1.1M | 199.43K | 705.14K | 392.49K | 1.45M | 722.8K | 139.87K | 96.69K | -366.08K | 1K |
Operating Cash Flow | -4.45M | -4.45M | -3.75M | -256.12K | -883.1K | -197.78K | -373.1K | -174.35K | -236.71K | -308.09K | -697.11K | n/a |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | 443.85K | n/a | n/a | -275K | -100K | -325K | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | -5.64M | n/a | 5.08M | 560.24K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -678.99K | -185.24K | 5.69M | n/a | n/a | 181.04M | 0.13 | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | -5.87M | -185.24K | 5.69M | 285.24K | -100K | 180.71M | 0.13 | n/a | n/a | -178.5M | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | 5.64M | n/a | -5.64M | n/a | n/a | -139.35M | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 5.61M | 571.68K | 571.68K | -5.42M | 525K | n/a | -138.7M | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 6.32M | 5.47M | 571.68K | -5.42M | 525K | n/a | -138.7 | n/a | n/a | n/a | n/a | n/a |
Net Cash Flow | 1.88M | 1.48M | 2.46M | 13.78K | -72.86K | -297.78K | 41.63M | -45.86K | -236.71K | -308.09K | -179.2M | n/a |
Free Cash Flow | -4.45M | -4.45M | -3.75M | -256.12K | -883.1K | -197.78K | -373.1K | -174.35K | -236.71K | -308.09K | -697.11K | n/a |